Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
25.89
+0.69 (2.74%)
At close: Apr 29, 2026

SHE:301246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
472.74745.59421.86395.19120.43
Short-Term Investments
-379.25292.3190-
Trading Asset Securities
1,128900.321,466--
Cash & Short-Term Investments
1,6012,0252,180485.19120.43
Cash Growth
-20.95%-7.10%349.31%302.89%-55.02%
Accounts Receivable
904.42559.44602.64660.21458.16
Other Receivables
46.779.89141.6787.645.85
Receivables
951.12639.33744.3747.8504.01
Inventory
319.01270.53191.51352.95384.48
Other Current Assets
425.86111.3486.4378.9820.72
Total Current Assets
3,2973,0463,2021,6651,030
Property, Plant & Equipment
2,3642,2921,9101,620891.27
Long-Term Investments
211.24203.64228.08335.12242.35
Other Intangible Assets
178.84181.89183.06173.62194.15
Long-Term Deferred Tax Assets
19.6617.2617.5621.2217.72
Long-Term Deferred Charges
4.085.525.956.8611.98
Other Long-Term Assets
89.5978.06103.953.2745.14
Total Assets
6,1655,8255,6513,8752,432
Accounts Payable
798.99777.27636.79934.95340.92
Accrued Expenses
34.0855.2857.5465.757.98
Short-Term Debt
60.0459.32-17.6420.1
Current Portion of Long-Term Debt
96.5777.0165.966.092.84
Current Portion of Leases
-0.740.60.560.53
Current Income Taxes Payable
27.233.561.1538.2945.65
Current Unearned Revenue
19.7913.8719.831.0129.66
Other Current Liabilities
204.51148.94133.04165.66120.05
Total Current Liabilities
1,2411,136914.831,320617.73
Long-Term Debt
368.34230.36276.12341.6747.22
Long-Term Leases
6.427.166.98.198.23
Long-Term Unearned Revenue
68.0868.6471.5570.4560.8
Long-Term Deferred Tax Liabilities
21.7321.6221.5421.3120.3
Total Liabilities
1,7061,4641,2911,762754.27
Common Stock
400.01400.01400.01352.75352.75
Additional Paid-In Capital
2,1772,1722,17222.1520.62
Retained Earnings
1,9251,8181,7861,7391,304
Treasury Stock
-47.15-32.8---
Comprehensive Income & Other
4.973.371.8900.46
Total Common Equity
4,4604,3614,3602,1141,678
Minority Interest
-0.730.47---
Shareholders' Equity
4,4594,3614,3602,1141,678
Total Liabilities & Equity
6,1655,8255,6513,8752,432
Total Debt
531.36374.59349.51434.1478.92
Net Cash (Debt)
1,0701,6511,83151.0541.51
Net Cash Growth
-35.20%-9.83%3485.91%22.99%-62.14%
Net Cash Per Share
2.694.144.720.140.12
Filing Date Shares Outstanding
409.17396.81399.9400.01352.75
Total Common Shares Outstanding
409.17397.89400.01352.75352.75
Working Capital
2,0561,9102,287345.02411.91
Book Value Per Share
10.9010.9610.905.994.76
Tangible Book Value
4,2814,1794,1771,9401,484
Tangible Book Value Per Share
10.4610.5010.445.504.21
Buildings
-833.02719.62395.96329.31
Machinery
-1,6491,470782.58657
Construction In Progress
-630.57375.86946.39334.11
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.